Trials / Completed
CompletedNCT01904045
PEL-1235_REN-0176-I (Pelicon)
A Multicentre, Prospective, Non-Interventional Study to Assess the Intra-patient Variability of Tacrolimus Once and Twice Daily After Kidney Transplantation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 51 (actual)
- Sponsor
- Technical University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim of this study is to investigate whether in patients following kidney transplantation (\>6 months after transplantation), the intra-patient variability of levels of tacrolimus is comparable after administration of tacrolimus twice daily (Prograf) to tacrolimus once daily (Advagraf), with each regimen for 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | tacrolimus Advagraf | intake of Advagraf once daily for 3 months |
| OTHER | tacrolimus Prograf | intake of Prograf twice daily for 3 months |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2018-01-01
- Completion
- 2018-08-01
- First posted
- 2013-07-22
- Last updated
- 2018-09-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01904045. Inclusion in this directory is not an endorsement.